M-L Dahl
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 7
- Inflammatory mediators and NSAID effects 2
- Biological Psychiatry top 10%
- Tryptophan and brain disorders 2
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment 3
- Gastroenterology top 10%
-
- Statistical Methods in Clinical Trials 2
-
- Diet and metabolism studies 2
-
- Psychiatric care and mental health services 1
-
- Estrogen and related hormone effects 1
- Co-authors
- Leif BertilssonAdrián LLerenaGunnel TybringMing ChangRein SeensaluUlf BondessonSara RamosL. Lindström
- Journals
- British Journal of Clinical Pharmacology (4 papers)Clinical Pharmacology & Therapeutics (2 papers)The Pharmacogenomics Journal (2 papers)
- Partner nations
- SwedenEstoniaUnited States
In The Last Decade
M-L Dahl
10 papers receiving 688 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 409
- Biological Psychiatry 37
- Psychiatry and Mental health 222
- Gastroenterology 62
- Pediatrics, Perinatology and Child Health 123
Countries citing papers authored by M-L Dahl
This map shows the geographic impact of M-L Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M-L Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M-L Dahl more than expected).
Fields of papers citing papers by M-L Dahl
This network shows the impact of papers produced by M-L Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M-L Dahl. The network helps show where M-L Dahl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M-L Dahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 25 | |
| 2 | 2012 | 0 | |
| 3 | 2007 | 70 | |
| 4 | 2007 | 116 | |
| 5 | 2003 | 13 | |
| 6 | 2002 | 37 | |
| 7 | 1995 | 166 | |
| 8 | 1995 | 47 | |
| 9 | 1994 | 234 | |
| 10 | [Genotyping for drug metabolism capacity can give valuable clinical information]. | 1992 | 2 |
| 11 | U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes. | 1984 | 1 |
About M-L Dahl
M-L Dahl is a scholar working on Pharmacology, Biological Psychiatry, Psychiatry and Mental health, Statistics and Probability and Pharmacology, having authored 11 papers that have together received 711 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Schizophrenia research and treatment (3 papers), Tryptophan and brain disorders (2 papers), Inflammatory mediators and NSAID effects (2 papers), Statistical Methods in Clinical Trials (2 papers), Diet and metabolism studies (2 papers), Psychiatric care and mental health services (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Pharmacology (409 citations), Biological Psychiatry (37 citations), Psychiatry and Mental health (222 citations), Gastroenterology (62 citations) and Pediatrics, Perinatology and Child Health (123 citations). M-L Dahl has collaborated with scholars based in Sweden, Estonia and United States. Frequent co-authors include Leif Bertilsson, Adrián LLerena, Gunnel Tybring, Ming Chang, Rein Seensalu, Ulf Bondesson, Sara Ramos, L. Lindström, J. Benítez and C. Alm. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The Pharmacogenomics Journal, Cancer Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.